Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma

Feng-Lin Dong,Zong-Zhen Xu,Ying-Qiao Wang,Tao Li,Xin Wang,Jie Li
DOI: https://doi.org/10.1186/s12951-024-02582-6
IF: 10.2
2024-05-31
Journal of Nanobiotechnology
Abstract:Advanced hepatocellular carcinoma (HCC) can be treated with sorafenib, which is the primary choice for targeted therapy. Nevertheless, the effectiveness of sorafenib is greatly restricted due to resistance. Research has shown that exosomes and circular RNAs play a vital role in the cancer's malignant advancement. However, the significance of exosomal circular RNAs in the development of resistance to sorafenib in HCC remains uncertain.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?